Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.1 With more than 90 decentralized clinical trials (DCT) underway across more than 40 countries and 30 indications, IQVIA has the experience, capabilities and reach to meet any sponsor's needs.

Contact Us

Scalable. Adaptable. Patient-Centric.

Nearly two-thirds of industry experts ranked IQVIA as the leader among hybrid trial solutions providers – more than any other technology or service provider.1 Our tested DCT models, unparalleled data, and comprehensive technology portfolio empower trial sponsors by expanding geographic reach and providing access to diverse populations and difficult-to reach candidates.

Built on a foundation of global clinical operations capabilities and deep therapeutic expertise, IQVIA Decentralized Trials help solve some of the toughest clinical study challenges.

1Industry Standard Research, 2021

IQVIA's Experience

90 studies in 40+ countries

IQVIA Decentralized Trials solutions
IQVIA's Experience

>210K subjects enrolled

in IQVIA Decentralized Trials across 30+ indications

5 of the top 10 pharma companies

IQVIA has delivered decentralized clinical trials (DCT) solutions for 5 of the top-10 pharma companies globally.
Accelerate Patient Recruitment
IQVIA taps unparalleled global data and analytics to identify the right patients wherever they are.
Strengthen Patient Engagement
IQVIA’s flexible DCT models greatly reduce patient burden by delivering studies directly to the patients in a concierge digital experience that supports participation wherever life takes them.
Improve Quality and Patient Safety
Decentralized trials can reduce variation in data collection and provide near real-time data to enhance safety signal detection.
Reduce Complexity and Trial Timelines
Digitally enabled workflows and engagement platforms simplify clinical trials processes leading to fewer errors and shorter timelines.
 The Human Data Science Company
man checking his smart phone
man checking his smart phone

Purpose-built DCT technology to boost study performance

At the center of IQVIA Decentralized Trials is a specialized, highly secure, scalable DCT platform. IQVIA Decentralized Clinical Trials Platform enables the orchestration of all hybrid and fully virtual study activities.

  • Telemedicine capabilities
  • Patient eDiaries and questionnaires
  • Intelligent workflow enabling better collaboration
  • Upload medical records and visit documents
  • Collaborate across key stakeholders and systems
  • Securely track IMP/lab kits shipped directly to patients

Available in dozens of languages, IQVIA’s DCT platform empowers patients across the globe with a concierge digital experience, including: text reminders, alerts, live chat, 24/7 support, and a scheduling tool to confirm or reschedule study visits.

woman with cancer spending time with grandson
woman with cancer spending time with grandson

Scalable, adaptable models that works for you

DCTs are not a one-size-fits all approach. Every trial setting and patient population has unique needs, and the DCT model must be customized to accommodate those needs and ensure success.

Our Decentralized Trials team leverages IQVIA’s deep therapeutic expertise, purpose-built technology, global investigator network and unparalleled data to tailor a fully remote or hybrid solution that meets your needs.

With experience delivering decentralized trials across the North America, Latin America, Europe and Asia-Pacific, IQVIA helps sponsors of all sizes accelerate timelines and achieve study goals through:

  • Hybrid approaches blending virtual trials and site-based elements
  • Long-term follow-up studies in a virtual environment
  • Side-by-Side comparison models with decentralized and traditional study arms
  • Specialized models digital therapeutics
Decentralized Clinical Trials Webinar Series
Join us each Tuesday in May as we highlight the value decentralized trials (DCT) models bring to clinical research and how a tech-enabled design approach can deliver more effective remote clinical trials and help solve some of the toughest clinical study challenges.

During this webinar series, experts will share insight on proven DCT strategies that help expand geographic reach, leveraging technologies and local infrastructure to gain access to intended populations while ensuring compliance and operational efficiencies throughout the study timeline.
Learn More
Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.